未知生产厂商
Nemolizumab is a humanized anti-human interleukin-31 receptor A (IL-31RA) monoclonal antibody used to treat pruritus associated with atopic dermatitis and prurigo nodularis.
Nemolizumab is a humanized anti-human interleukin-31 receptor A (IL-31RA) monoclonal antibody used to treat pruritus associated with atopic dermatitis and prurigo nodularis.
By competitively binding to IL-31RA, nemolizumab inhibits the binding of IL-31 to its receptor and subsequent intracellular signaling, thereby suppressing pruritus.
共 2 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
